The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Trends in survival for both histologic types of esophageal cancer in U.S. surveillance, epidemiology and end results areas
Open accessAbstract
An analysis of temporal trends for esophageal cancer patients diagnosed in 1961–1996 in Sweden showed improvement in relative survival rates (RSRs), but data were not available on stage at diagnosis or on cancer-directed treatment.1 The present report considers temporal changes in RSRs by histology for esophageal cancer patients in the United States. The National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program of high-quality cancer registries, established in 1973 and regarded as generally representative of the entire United States.2 Data were obtained for the 9 SEER areas (Connecticut; Detroit, MI; Hawaii; Iowa; New Mexico; San Francisco–Oakland, CA; Seattle, WA; Utah; and, since 1975, Atlanta, GA). Patients with esophageal cancer as the first or only reportable cancer were identified, excluding those ascertained only by death certificate or autopsy. Using a computer program that includes mortality rates for the general U.S. population (by age, sex and race),3 RSRs at 1, 3 and 5 years after diagnosis in 1975–1979, 1980–1984, 1985–1989, 1990–1994 and 1995–1998 were obtained for squamous cell carcinoma and adenocarcinoma of the esophagus (defined by ICD-O-2 morphology codes).4 Confidence limits on RSRs were estimated as ± twice the SE (p = 0.05).3 RSRs by histologic group are not routinely included in SEER reports,2 and a SEER monograph on histology included data for cancers diagnosed only through 1986.4, 5 Another SEER study was limited to esophageal adenocarcinoma, showing slight increases in RSRs in the 1980s vs. earlier years.6 RSRs increased over time for both squamous cell and adenocarcinoma (Table I), beginning earlier than in Sweden.1 The overall increases from 1975–1979 to 1995–1998 were similar for the 2 histologic groups (e.g., ratios of 3-year RSRs were 2.2 for squamous cell carcinoma and 2.1 for adenocarcinoma), but the larger sample sizes for squamous cell carcinoma in the earlier years resulted in statistical significance for more comparisons than for adenocarcinoma. Age-standardized incidence rates for adenocarcinoma of the esophagus in the SEER program have surpassed the declining rates for squamous cell carcinoma.7 For squamous cell carcinoma patients, RSRs were statistically significantly higher in 1980–1984 vs. 1975–1979 and in 1985–1989 vs. 1980–1984 (except for the 5-year RSR); thereafter, increases were smaller (Table I). RSRs were slightly higher for adenocarcinoma than for squamous cell carcinoma, but differences were not statistically significant (except for 1-year RSRs in 1995–1998). Increases in RSRs were evident for both males and females. For example, 3-year RSRs increased from 1975–1979 to 1995–1998 from 6.4% to 15.2% in males and from 9.8% to 18.5% for females for squamous cell carcinoma and from 10.3% to 20.7% in males and from 6.6% to 18.6% in females for adenocarcinoma (data not shown). Increases in RSRs could reflect improvements in detection resulting from the use of endoscopy (starting in the 1980s).1 Data on SEER historical summary stage (local, regional, distant or unknown) were available for all years of diagnosis. Using the data in Tables I and II, the proportion of esophageal cancers diagnosed at an early (localized) stage decreased slightly for squamous cell carcinoma (33.0% in 1975–1979 to 28.1% in 1995–1998) but increased slightly for adenocarcinoma (19.9% to 25.3%). However, increases in RSRs were evident within the local-stage group for both squamous cell carcinoma and adenocarcinoma (Table II). Differences in RSRs between squamous cell and adenocarcinoma patients were larger within local stage (Table II) than for all stages combined (Table I). The survival difference by histology may have been influenced by the detection of superficially invasive adenocarcinomas during surveillance of Barrett's esophagus patients,5, 8 but the differences in RSRs were evident even in 1975–1979 (i.e., prior to the spread of endoscopy). Improvements in treatment of local- and regional-stage cancers could have resulted in temporal increases in RSRs. However, RSRs increased over time among local- and regional-stage cancer patients who had neither cancer-directed surgery nor radiotherapy coded in the SEER database, though little or no improvement was evident from 1990–1994 to 1995–1998 (Table III). Among patients with radical surgery (i.e., partial or total esophagectomy plus partial or total removal of other organs), coded in the SEER database only for diagnoses in 1988 and later, samples were small but improvement in survival was evident (albeit not statistically significant) for adenocarcinoma and not for squamous cell carcinoma (Table IV). Any reductions in mortality (after esophagectomy) due to improvements in perioperative care during the last 2 decades9 should have affected RSRs for both histologic types. However, the possibility that increasingly earlier detection of adenocarcinomas, due to endoscopic screening of the distal esophagus for Barrett
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Cited by
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
The Burden of Gastrointestinal and Liver Diseases, 2006
Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00723.x · Cited by 691
Trends in esophageal adenocarcinoma incidence and mortality
Hur, C., Miller, M., Kong, C. Y., Dowling, E. C., Nattinger, K. J., Dunn, M., & Feuer, E. J. (2013) · Cancer · doi:10.1002/cncr.27834 · Cited by 507
Yousef, F., Cardwell, C., Cantwell, M. M., Galway, K., Johnston, B. T., & Murray, L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn121 · Cited by 403
Njei, B., McCarty, T. R., & Birk, J. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13289 · Cited by 351
Metadata
- Authors
- Polednak, A. P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-02-13
- Volume
- 105
- Issue
- 1
- Pages
- 98-100
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2059497743
- Cited by
- 176
- References
- 1
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.